# Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci

> **NCT00428844** · PHASE2 · COMPLETED · sponsor: **Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)** · enrollment: 75 (actual)

## Conditions studied

- Osteomyelitis

## Interventions

- **DRUG:** daptomycin
- **DRUG:** daptomycin
- **DRUG:** vancomycin
- **DRUG:** teicoplanin
- **DRUG:** nafcillin
- **DRUG:** oxacillin
- **DRUG:** flucloxacillin

## Key facts

- **NCT ID:** NCT00428844
- **Lead sponsor:** Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06-26
- **Primary completion:** 2010-03-26
- **Final completion:** 2010-06-23
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2018-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00428844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00428844, "Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT00428844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*